Article
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies
18 Jul 2021
Abstract excerpt
Introduction: The treatment scenario of lung cancer is rapidly evolving through time. In parallel, growing evidence is accumulating on different mechanisms of treatment resistance. Inter- and intra-tumor heterogeneity define the spatial and temporal tumor clonal evolution, that is at the basis of tumor progression and resistance to anticancer treatments.Areas covered: This review summarizes the available evidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
